UCLA Study Uncovers Widespread Global Deficit in Pediatric Palliative Care

A groundbreaking study recently published in The Lancet Child & Adolescent Health sheds crucial light on the evolving landscape of pediatric serious health-related suffering (SHS) and the urgent unmet need for specialized palliative care worldwide. The report reveals that nearly all of the 10.6 million children experiencing SHS today reside in low- and middle-income countries, where access to appropriate palliative care remains distressingly limited. This comprehensive analysis marks a pivotal moment in understanding how prolonged survival with chronic, severe illnesses necessitates a fundamental rethinking of healthcare strategies for children on a global scale.

The study pioneers a refined, child-specific methodology for estimating SHS, an umbrella term encapsulating the multifaceted physical, psychological, social, and spiritual distress that arises from life-threatening or life-limiting conditions. Building upon frameworks established by the Lancet Commission on Global Access to Palliative Care and Pain Relief, researchers leveraged the latest data from the 2023 Global Burden of Disease Study and convened an international expert panel of pediatric palliative care clinicians and scholars. This collaboration provided the backbone for identifying 21 distinct health conditions peculiar to children’s symptom burdens, thereby generating the most comprehensive assessment to date of pediatric palliative care needs across diverse socioeconomic contexts.

Results from this rigorous inquiry highlight a striking demographic and epidemiologic shift over the past three decades. In 1990, a majority of children with SHS were primarily positioned at the end of life, but by 2023, a substantial 81% are living with severe chronic conditions necessitating long-term palliative interventions. This surge in chronic illness survivorship, predominantly in low- and middle-income regions, signals an urgent call for healthcare systems to adapt to prolonged care demands rather than episodic, end-of-life crisis management. Notably, the decline in pediatric HIV-related mortality fueled this transition, underscoring the profound impact of public health advancements while simultaneously expanding the palliative care population.

Endocrine, metabolic, blood, and immune disorders (EMBID) emerge as the leading contributors to pediatric SHS, accounting for more than half of the suffering burden. Prematurity and birth trauma constitute the second largest category, followed by injuries. The underlying causes reflect a complex interplay of socioeconomic, environmental, and healthcare infrastructure factors that vary markedly between income levels. For instance, while HIV remains a significant cause of SHS in low-income countries, congenital malformations predominate in lower-middle-income regions, and hematologic malignancies like leukemia are more prevalent in upper-middle-income settings. High-income countries primarily grapple with injuries and external causes, revealing divergent epidemiological profiles that necessitate tailored regional care responses.

From a policy perspective, the study unveils a stark disparity: although the global pediatric SHS burden is immense, resources remain disproportionately allocated, with pediatric palliative care programs severely underfunded and understaffed, especially in areas where they are most desperately needed. The previously estimated figure of $1 million per year to procure adequate pain medication for all affected children in low-income countries starkly contrasts with the ongoing neglect seen in international health funding and policymaking. This inequity highlights the ethical imperative to embed pediatric palliative care as a central component of universal health coverage schemes globally.

Researchers further emphasize that the ramifications of chronic SHS extend beyond the affected children to their families and communities, compounding poverty and social marginalization. Multidimensional pain—encompassing physical agony, psychological trauma, social isolation, and spiritual distress—demands holistic, interdisciplinary approaches. As the pediatric population with chronic illness grows, health systems must prioritize competency-based training for healthcare professionals across all levels, ensuring they possess the knowledge and skills to deliver nuanced care attuned to children’s unique developmental and psychosocial needs.

Technological and pharmacological innovations, including the development and distribution of child-appropriate opioid formulations, are highlighted as critical enablers of effective symptom management. However, access barriers persist, compounded by legal restrictions, societal stigma surrounding opioid use, and logistical challenges in many resource-limited settings. Alleviating these obstacles requires coordinated policy reform, international advocacy, and patient-centered approaches that prioritize safety alongside efficacy.

The research team calls for ongoing refinement of pediatric palliative care metrics and methodologies, recognizing that the duration and complexity of care demands continue to evolve, particularly in the context of emerging health threats like the long-term sequelae of COVID-19. Incorporating patient and family perspectives into future research will be instrumental in crafting responsive interventions that address quality of life dimensions often overlooked in clinical assessments.

Comprehensive integration of palliative care into national and international health policies stands out as a non-negotiable priority. This integration includes ensuring the availability of essential medicines, expanding healthcare workforce capacity, and fostering sustainable financing mechanisms. The necessity for collaborative global action is underscored by the disproportionate concentration of pediatric SHS in underserved regions, where health infrastructure deficiencies exacerbate suffering and restrict access to fundamental care.

Co-lead author Dr. Felicia Marie Knaul, a distinguished professor at UCLA Health’s David Geffen School of Medicine, encapsulated the study’s core message: the extensive suffering endured by children, especially those in poverty, has remained largely invisible within global health agendas. As medical advances enable children to live longer with chronic conditions, health systems must urgently recalibrate to meet this changing reality, committing to adequately funded, child-specific policies that minimize avoidable suffering and uphold dignity.

The detailed analysis presented is designed to inform and influence policymakers, funders, healthcare providers, and advocates worldwide. By illuminating the shifting epidemiology and rising prevalence of pediatric SHS, the study lays a data-driven foundation for targeted resource allocation, program development, and regulatory adjustments essential to transforming pediatric palliative care provision across the globe.

In sum, this landmark investigation not only quantifies the expansive, growing need for pediatric palliative care but also provides a strategic blueprint for action. Addressing this challenge effectively demands a multisectoral commitment to equity, innovation, and compassionate care that recognizes and responds to the complex realities of children with serious health-related suffering. Without bold, coordinated efforts, millions of vulnerable children will continue to endure preventable pain and distress, an incongruity that global health cannot allow to persist.

News Publication Date:
10-Feb-2026

Web References:
https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(25)00338-4/fulltext

References:
“The global need for paediatric palliative care: an analysis of the evolution of serious health-related suffering in children aged 0–19 years from 1990 to 2023.” The Lancet Child & Adolescent Health, March 2026. DOI: S2352-4642(25)00338-4